Related Experiment Video
Updated: Nov 19, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Structural hemoglobinopathies: Analysis of 128 cases and their relevance in the diabetic control
1Clinical Biochemistry Department, Clinical University Hospital of Salamanca, Salamanca, Spain.
Insights
Structural hemoglobinopathies, genetic blood disorders, are increasingly detected during HbA1c testing in Europe. This study found a low incidence of these variants, highlighting the need for alternative monitoring methods for diabetic patients.
Area of Science:
- Clinical Chemistry
- Hematology
- Genetics
Background:
- Hemoglobinopathies are autosomal recessive monogenic disorders.
- Increased migration in Europe leads to higher prevalence in non-endemic regions.
- HbA1c testing for diabetes mellitus can incidentally detect hemoglobin variants.
Observation:
- HPLC equipment was used to evaluate 65,000 patients for glycaemic monitoring.
- 128 variants were identified, with an incidence of 0.19% in the study population.
- Heterozygous S hemoglobinopathy was the most frequent variant, particularly in the foreign population.
Findings:
- The study identified a lower incidence of structural hemoglobinopathies than estimated for Spain.
- Primary Health Centers identified a significant portion of these variants (82).
- Three patients with HbS/HbS (sickle cell anemia) were detected.
Implications:
- Structural hemoglobinopathies can interfere with accurate HbA1c testing.
- Alternative methods like glycated protein studies are recommended for monitoring diabetic therapy in affected individuals.
- Early identification and management strategies are crucial, especially in diverse populations.
Background And Objectives:
Hemoglobinopathies are monogenic disorders with autosomal recessive inheritance. In Europe, with increased migration flows these conditions are appearing more frequently in non-endemic regions. HbA1c testing is useful for evaluating long-term glycaemic status in diabetes mellitus patients. During HbA1c evaluation, other hemoglobin fractions are detected, such as structural hemoglobinopathies. The principal objective of this work is to study the incidence of structural hemoglobinopathies in our area and their management.
Material And Methods:
Total population of 65,000 patients for glycaemic monitoring was evaluated with HPLC equipment (HPLC-ARKRAY® ADAMS, Menarini Diagnostics, Italy). This equipment quantifies different hemoglobin fractions.
Results:
We identified a total of 128 variants, representing an incidence with respect to the study population of 0.19% (1.97‰). Most (69) were identified in the foreign population, and the most frequent variant identified was heterozygous S hemoglobinopathy. In six families, structural hemoglobinopathy was identified. Three patients with HbS/HbS were detected. Primary Health Centers were the origin of an important part of these variants (82).
Conclusions:
Our study describes a low incidence for structural variants compared with the estimated incidence in Spain. These variants can interfere with HbA1c testing. In these cases, glycated protein study is an appropriate alternative to monitor diabetic therapy.
Related Concept Videos
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oxygen Transport in the Blood

